The transcription factor DDIT3 is a Potential Driver of Dyserythropoiesis in Myelodysplastic Syndromes
收藏NIAID Data Ecosystem2026-05-02 收录
官方服务：
资源简介：
This SuperSeries is composed of the SubSeries listed below. Refer to individual Series
应用场景：
创建时间：
2024-06-28
相关数据集
Supplementary Material for: Copper Deficiency Mimicking Myelodysplastic Syndrome: Zinc Supplementation in the Setting of COVID-19
While copper deficiency is rare, it can have serious consequences, including pancytopenia and neuropathy. This treatable vitamin deficiency can present very similarly to myelodysplastic syndrome (MDS)
DataCite Commons2023-07-22 更新80
Additional file 1: Table S1. of Transfer RNA detection by small RNA deep sequencing and disease association with myelodysplastic syndromes
Sample description. Table S2. Phenotype and alignment results for all samples. Table S3. Differential expression analysis between MDS and control samples. Table S4. Differential expression analysis be
DataCite Commons2024-12-16 更新60
Additional file 1 of AQP0 is a novel surface marker for deciphering abnormal erythropoiesis
Additional file 1: Figure S1. Characterization of erythropoiesis of patients using three surface markers (CD71, CD235a, and AQP0). Flow cytometry analysis of erythropoiesis of patient 1 (A), patient 2
NIAID Data Ecosystem40
ZRSR1 cooperates with ZRSR2 in regulating splicing of U12-type introns in murine hematopoietic cells II. ZRSR1 cooperates with ZRSR2 in regulating splicing of U12-type introns in murine hematopoietic cells II
Recurrent loss-of-function mutations of spliceosome gene, ZRSR2, occur in myelodysplastic syndromes (MDS). Mutation/loss of ZRSR2 in human myeloid cells primarily causes impaired splicing of the U12-t
NIAID Data Ecosystem80
Physicians’ experience in blood supply shortages and the top factors that impact the clinical, economic, and humanistic outcomes of patients with myelodysplastic syndromes in 5 European countries
Blood supply shortages may create unnecessary burden, including treatment delay, worsened quality of life, or increased healthcare resource utilization in patients with myelodysplastic syndromes (MDS)
DataCite Commons2023-01-30 更新50
